Pathstone Family Office’s Acumen Pharmaceuticals ABOS Stock Holding History

Pathstone Family Office’s Portfolio ABOS Stock Details ABOS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.99M	Buy
2023 Q2	$2.25M	Buy
2023 Q1	$1.59M	Sell
2022 Q4	$5.73M	Buy
2022 Q3	$5.08M	Buy